Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Candidatus dermatophostum as a novel genus of polyphosphate-accumulating organisms for high-strength wastewater treatment

2 months ago
Dermatophilaceae polyphosphate-accumulating organisms (PAOs), formerly classified as Tetrasphaera PAOs, play pivotal roles in enhanced biological phosphorus removal (EBPR). However, their phylogenetic diversity, ecological preferences, and metabolic traits remain poorly characterized, and a robust marker gene for their classification is lacking. Here, we performed an extensive phylogenomic and metabolic analysis of Dermatophilaceae PAOs utilizing 46 newly recovered metagenome-assembled genomes...
Hui Wang

Social media support groups for youth nicotine vaping cessation: a randomized clinical trial

1 month 3 weeks ago
CONCLUSIONS: Social media support groups were acceptable to diverse young people and improved abstinence rates on average over 6 months compared to quitline referral.
Pamela M Ling

Oxycodone induces HMGB1-mediated neuroimmune crosstalk between oligodendrocytes and microglia

1 month 3 weeks ago
Emerging evidence implicates opioid exposure in glial dysfunction and neuroimmune signaling. However, the role of oligodendrocytes in opioid-induced neuroinflammation remains poorly understood. Here, we demonstrate that oxycodone exposure upregulated high mobility group box 1 (HMGB1), a danger-associated molecular pattern (DAMP), in mature oligodendrocytes (OLs) but not oligodendrocyte precursor cells (OPCs). Oxycodone treatment significantly increased cytoplasmic translocation and extracellular...
Malabika Maulik

Ras-Associated Autoimmune Leukoproliferative Disorder Manifesting in an Adult Patient as a Lupus-Like Syndrome and Demonstrating Bone Marrow and Peripheral Blood Findings Reminiscent of Chronic Myelomonocytic Leukemia

1 month 3 weeks ago
Ras-associated autoimmune leukoproliferative disorder (RALD) is a rare, clonally derived leukoproliferative disorder that often affects the pediatric population and can show a variety of systemic, autoimmune symptoms. We describe an adult RALD patient clinically presenting with a lupus-like syndrome and demonstrating bone marrow and peripheral blood findings reminiscent of chronic myelomonocytic leukemia (CMML). This challenging presentation of a rare disease highlights the difficulty in...
Ryan Lofton

Long-term management challenges in postmyopathic dermatomyositis

1 month 3 weeks ago
A 35-year-old woman was initially diagnosed with classic dermatomyositis (DM) at age 21. We cared for her during 11 of those 14 years. Traditional immunosuppressive treatments did not control her DM skin disease activity. She was subsequently observed to have a juvenile-onset DM phenotype. For the past 11 years, her skin and muscle disease activity had been only partially controlled with monthly high-dose intravenous immunoglobulin (IVIG) therapy. During those 11 years of IVIG therapy, her skin...
Brenna G Kelly

Pagination

  • Previous page ‹ Previous
  • Page 103
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies